Thirty-two of the thirty-three sermorelin sellers reviewed on this site sell it as a prescription drug. It is compounded, not FDA-approved. The one exception, Care Bare Rx, turns out not to sell sermorelin in any form at all, despite being approved to advertise here. So a real screening step sits between “add to cart” and a package arriving, at nearly every seller on this roster. What that step actually asks a buyer is one of the least-published details in the category. That gap is itself worth reporting plainly.
The one fact almost every seller states
Every branded sermorelin ever approved in the US was a product called Geref. It was discontinued years ago, as a business decision, not a safety finding (the full FDA record is here). Nothing has replaced it. That single fact, repeated across a majority of this site’s provider reviews, is why a prescription sits in front of nearly every order. What ships today is compounded to order by a pharmacy, not dispensed as an FDA-reviewed finished drug. See what a compounding pharmacy actually has to show for that. A compounding pharmacy generally requires a valid, patient-specific prescription before it will fill anything. Thirty-two of the thirty-three reviews confirm that requirement directly. The intake exists to produce that prescription. What happens during it is a separate question, and the sellers themselves rarely answer it.
What gets asked, according to the sellers’ own pages
Only two of the thirty-three reviews describe the intake process by name. RxSpan MD gates its ongoing sermorelin rate behind what its own page calls an intake quiz. That is a notable gate: the same seller publishes a full pricing ladder for its GLP-1 plans with no quiz required. So it is specific to how RxSpan MD currently handles sermorelin, not how it prices everything. Breeze Meds describes its process as “a medical intake built for sermorelin therapy, not a generic peptide questionnaire.” That language distinguishes it from a form built for a different product. Neither page quotes a single question a buyer is actually asked.
CoreAge Rx puts its price on the homepage rather than behind an intake. That is unusual, this site’s review of it notes, for a product the seller otherwise treats as secondary. What that homepage does not carry is anything past the price. How the rate moves across plan lengths, how a dose gets chosen, and what the consultation involves are all answered after a buyer starts, not before.
Fitish RX ties its flat $149-a-month rate to “the provider consult, medication if approved, and delivery.” “If approved” is the only place, across all thirty-three reviews, where a seller’s own page acknowledges in writing that the outcome is not guaranteed.
Price ahead of intake, process behind it
At several sellers, the price is visible before a buyer starts anything. bmiMD’s tablet and injection prices both sit on the product page “ahead of any intake,” per this site’s review, verified July 31, 2026. Strut Health’s oral and injectable rates are described the same way. Both are visible on the page itself before any form is opened. That is a real, checkable fact for those sellers: the cost does not require starting the process. The process itself is a different matter. Knowing the price in advance does not mean knowing what the intake will ask.
What the reviews do not establish, and why that is the finding
Every review in this site’s corpus carries a field built to record whether a seller states its bloodwork policy: “Included,” “Not stated” or “Extra cost.” It was never populated on a single one of the thirty-three reviews. That is not evidence that bloodwork is skipped everywhere on this roster. It means none of the thirty-three sellers’ pages state a policy clearly enough, in either direction, for this site to publish a value at all. See what published sermorelin bloodwork guidance actually covers.
The same is true of a live phone or video call: none of the thirty-three reviews states whether one happens, synchronously or otherwise. None states how quickly a prescription follows a completed intake. Only one seller, Fitish RX, states which states it will not ship to. Only one, CoreAge Rx, states a LegitScript claim on its own page — a claim this site’s review records, not one independently verified elsewhere. Only four of the thirty-three state an actual milligram dose anywhere on the page. Those are Fitish RX’s nightly 3 mg protocol, Idgie Health’s 300 mcg and 500 mcg oral tiers, MintRx’s 500 mcg injected dose, and Try Ageless’ 15 mg dosage table.
The honest shape of a sermorelin intake, from what is published
Put together, what this roster actually supports is narrower than the category’s marketing suggests. A buyer can often learn the price before starting anything. A buyer can expect a real prescription requirement at all but one of thirty-three sellers. What gets dispensed there is compounded, not FDA-approved. What a buyer generally cannot learn from a seller’s own page is what the screening itself asks, whether labs are involved, or how long approval takes. That is true at the cheapest sellers and the most price-transparent ones alike. The gap runs across this entire roster. It is not a signal, one way or the other, about which sellers are more careful. It is a gap in what gets published, full stop. A buyer weighing where to start can compare what is actually priced on the sermorelin telehealth board, and ask the remaining questions directly before an intake begins.